157 related articles for article (PubMed ID: 30384806)
1. MicroRNA-22 Suppresses Breast Cancer Cell Growth and Increases Paclitaxel Sensitivity by Targeting NRAS.
Song YK; Wang Y; Wen YY; Zhao P; Bian ZJ
Technol Cancer Res Treat; 2018 Jan; 17():1533033818809997. PubMed ID: 30384806
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer.
Liu X; Lv X; Yang Q; Jin H; Zhou W; Fan Q
Technol Cancer Res Treat; 2018 Jan; 17():1533033818758905. PubMed ID: 29495918
[TBL] [Abstract][Full Text] [Related]
3. MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast Cancer.
Liu MM; Li Z; Han XD; Shi JH; Tu DY; Song W; Zhang J; Qiu XL; Ren Y; Zhen LL
Sci Rep; 2017 Nov; 7(1):15929. PubMed ID: 29162879
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-19b Promotes Nasopharyngeal Carcinoma More Sensitive to Cisplatin by Suppressing KRAS.
Zhang Y; Zhao Y; Liu L; Su H; Dong D; Wang J; Zhang Y; Chen Q; Li C
Technol Cancer Res Treat; 2018 Jan; 17():1533033818793652. PubMed ID: 30231694
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
[TBL] [Abstract][Full Text] [Related]
6. NT21MP negatively regulates paclitaxel-resistant cells by targeting miR‑155‑3p and miR‑155-5p via the CXCR4 pathway in breast cancer.
Wang Y; Yan L; Zhang L; Xu H; Chen T; Li Y; Wang H; Chen S; Wang W; Chen C; Yang Q
Int J Oncol; 2018 Sep; 53(3):1043-1054. PubMed ID: 30015868
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
8. miR-410-3p suppresses breast cancer progression by targeting Snail.
Zhang YF; Yu Y; Song WZ; Zhang RM; Jin S; Bai JW; Kang HB; Wang X; Cao XC
Oncol Rep; 2016 Jul; 36(1):480-6. PubMed ID: 27221455
[TBL] [Abstract][Full Text] [Related]
9. microRNA-181a-5p impedes the proliferation, migration, and invasion of retinoblastoma cells by targeting the NRAS proto-oncogene.
Ouyang M; Liu G; Xiong C; Rao J
Clinics (Sao Paulo); 2022; 77():100026. PubMed ID: 35339759
[TBL] [Abstract][Full Text] [Related]
10. MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1.
Gao J; Li L; Wu M; Liu M; Xie X; Guo J; Tang H; Xie X
PLoS One; 2013; 8(6):e65138. PubMed ID: 23750239
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-7 inhibits multiple oncogenic pathways to suppress HER2Δ16 mediated breast tumorigenesis and reverse trastuzumab resistance.
Huynh FC; Jones FE
PLoS One; 2014; 9(12):e114419. PubMed ID: 25532106
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells.
Chai C; Wu H; Wang B; Eisenstat DD; Leng RP
Carcinogenesis; 2018 Sep; 39(9):1185-1196. PubMed ID: 29985991
[TBL] [Abstract][Full Text] [Related]
14. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
[TBL] [Abstract][Full Text] [Related]
15. miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS.
Fiore D; Donnarumma E; Roscigno G; Iaboni M; Russo V; Affinito A; Adamo A; De Martino F; Quintavalle C; Romano G; Greco A; Soini Y; Brunetti A; Croce CM; Condorelli G
Oncotarget; 2016 Apr; 7(15):19531-47. PubMed ID: 26799668
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.
Sui Y; Zhang X; Yang H; Wei W; Wang M
Oncol Rep; 2018 Feb; 39(2):473-482. PubMed ID: 29207145
[TBL] [Abstract][Full Text] [Related]
17. MiR-4282 inhibits proliferation, invasion and metastasis of human breast cancer by targeting Myc.
Zhao J; Jiang GQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8763-8771. PubMed ID: 30575917
[TBL] [Abstract][Full Text] [Related]
18. Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2.
Zhou Q; Guo J; Huang W; Yu X; Xu C; Long X
Mol Oncol; 2020 Sep; 14(9):2231-2250. PubMed ID: 32335998
[TBL] [Abstract][Full Text] [Related]
19. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
[TBL] [Abstract][Full Text] [Related]
20. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
